Hello ,
This publication started in 2012 as a joke that got out of hand. This month it turned 15.
Coffee ready? Here’s what you may enjoy reading.
Fifteen years of Vitiligo News, roughly 25,000 readers, one oddly persistent newsletter — and yes, cake.
It began as occasional notes about a quiet field. It is now a running record of how vitiligo science, advocacy, industry, AI and patient communities changed. Longer pieces live on the website. This letter stays a guidepost.
One shared concern, including in three papers this year: vitiligo science has moved forward faster than routine care.
We took apart the VRF Clinical Trials Hub and rebuilt it. An AI agent now reads major public trial registries, organizes the information and turns rather unfriendly registry records into something a normal human can browse. A person still checks the output.
Clinical trials in vitiligo cover a surprisingly wide range. A study may test a cream, a pill, a procedure, or a combination. Some simply follow people over time, – no experimental treatment at all. Ages run from 2 to 70+.
And the geography is now truly global: the United States and Canada, Latin America, India, Europe, the Middle East and Asia.
If this is unfamiliar territory, wait. A dedicated issue is coming. We'll explain what joining one actually means, what the different phases are, what questions to ask — and when the sensible answer may simply be no.
For now, have a look around.
It still helps you find doctors, support organizations, researchers, events and clinical trials around the world. But underneath, something larger is taking shape.
The map is gradually becoming the public-facing layer of the Global Vitiligo Observatory — a longer project to document the collective memory of the global vitiligo movement. The beta version already maps dozens of events across multiple years.
Ideally this needs its own explainer. This is the short version until that explainer arrives.
The Observatory is not a soft launch buried in a footer. It rolls out at the World Vitiligo Day 2026 closing event in Goa: The Human Side of Vitiligo.
Chandigarh carried the science. Goa carries the rest of the journey — diagnosis, treatment decisions, family, school and work.
Also on the agenda: the National Vitiligo Atlas of India and the announcement of the host city for World Vitiligo Day 2027.
We have finally pulled together our scattered collection of vitiligo arts, books and movies into one proper home. A small corner of the website, perhaps. But sometimes culture changes how people see a disease long before medicine changes how they treat it.
Can someone with vitiligo join the military? Stay in service? Claim that vitiligo was caused or worsened by service?
From the last newsletter one piece has kept travelling. Those three questions open three different files. National rules differ, accession and retention use different standards, and the calendar proves timing — not cause.
The accompanying podcast episode follows the patient journey in military: from sick call to civilian care — medical fitness, deployment, records, VA care and claims.
Fifteen years in, the field is noisier, faster and harder to ignore.
The job of this letter is still the same: point you to what is worth reading or listening, and leave the rest alone.
Have some cake.![]()
— Yan Valle
CEO, Vitiligo Research Foundation
This newsletter stays free so anyone living with vitiligo can read it without hitting a paywall. That only works if enough people decide the work is worth supporting.
If you find it useful, buy us a coffee and a muffin. Technically that is a small donation. Practically it keeps the research, the fact-checking and the writing moving.
Free to read. Independent by design.